(Q44002457)

28 November 2017

title

Neutrophil gelatinase-associated lipocalin levels associated with cardiovascular disease in chronic kidney disease patients (English)

1 reference

28 November 2017

main subject

cardiovascular disease

1 reference

chronic renal insufficiency

inferred from title

1 reference

3

1 reference

28 November 2017

Fumihiko Furuya

1

1 reference

28 November 2017

Hiroki Shimura

2

1 reference

28 November 2017

Kazuya Takahashi

4

1 reference

28 November 2017

Daiichiro Akiyama

5

1 reference

28 November 2017

Chikako Asakawa

6

1 reference

28 November 2017

Ayako Okamura

7

1 reference

28 November 2017

Ai Motosugi

8

1 reference

28 November 2017

Kazutaka Haraguchi

9

1 reference

28 November 2017

Zentaro Yamagata

10

1 reference

28 November 2017

Tetsuro Kobayashi

11

1 reference

28 November 2017

publication date

12 December 2013

1 reference

Clinical and experimental nephrology

28 November 2017

published in

1 reference

28 November 2017

volume

18

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

778-783

1 reference

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Effects of anemia correction by erythropoiesis-stimulating agents on cardiovascular function in non-dialysis patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Low serum testosterone increases mortality risk among male dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Natriuretic peptides and NGAL in heart failure: does a link exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

The Ngal reporter mouse detects the response of the kidney to injury in real time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Expression of Neutrophil Gelatinase–Associated Lipocalin in Atherosclerosis and Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0923-4

Cardio-ankle vascular index to screen cardiovascular diseases in patients with end-stage renal diseases

21 January 2018

1 reference

12 December 2020

Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease

1 reference

12 December 2020

Low plasma DHEA-S increases mortality risk among male hemodialysis patients

1 reference

12 December 2020

Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury

1 reference

12 December 2020

Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis

1 reference

12 December 2020

10.1007/S10157-013-0923-4

Identifiers

DOI

1 reference

28 November 2017

1 reference